<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220305054184N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-03-23</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of aromatherapy of two essential oils of jasmine and bitter orange on the level of anxiety in children</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of aromatherapy of two essential oils of jasmine and bitter orange on the level of anxiety in children referred to the clinic of Mohammad Kermanshahi Hospital in Kermanshah In a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62295</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, block randomization method with 6 blocks will be used. A random sequence will be created by an epidemiologist using the site https://www.sealedenvelope.com, and people who assign patients to groups will not be aware of the random sequence. Each person will be assigned a code in this method and only the epidemiologist will know which group these codes belong to. Therefore, hiding the random process will be fully observed; In addition, registration and assignment of patients to study groups will be done by the first and second implementers of the research project. Samples will be randomly assigned to three groups using block randomization method with 6 blocks. Blocking is usually used to balance the number of samples assigned to each of the groups studied. This feature helps researchers to equate the number of samples assigned to each of the study groups in cases where intermediate analyzes are required during the sampling process. Blocking is done in two ways. In this method, the size of the blocks is randomly selected (for example, blocks 6, 8, 10 and 14 in each block with an equal number of each group).</study_design>
      <phase>3</phase>
      <hc_freetext>Anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The substance used in this study in connection with intervention group 1 will contain jasmine essential oil. The electric fragrance diffuser will be used in the patients' presence space on the assigned days according to the sections mentioned). The device will start 30 minutes before the patient is present. Based on clinical experience and to receive essential oil with a constant medium concentration, 2 ml of essential oil will be used. The timer will be set to activate every 10 minutes for 2 minutes. To assess anxiety, children will first be interviewed using the face image scale (FIS) tool. The FIS scale consists of a row of five figures arranged from very happy to very dissatisfied. Children are asked to indicate which face best describes their feelings at that moment. This scale is scored by giving the value of one to the most positive face and five to the most negative face. One interview will be done before the intervention and the other after the intervention. In the next step, in order to increase the confidence and also to reduce the percentage of errors in execution and the results of the study, the child's cortisol level (measured with a commercial kit), heart rate and blood pressure will be measured by the doctor before and after the intervention. Intervention 2: Intervention group 2: The substance used in this study in connection with intervention group 2 will include bitter orange essential oil. An electric fragrance diffuser will be used in the patient's presence space (on assigned days according to the sections mentioned). The device will start 30 minutes before the patient is present. Based on clinical experience and to receive essential oil with a constant medium concentration, 2 ml of essential oil will be used. The timer will be set to activate every 10 minutes for 2 minutes. To assess anxiety, children will first be interviewed using the face image scale (FIS) tool. The FIS scale consists of a row of five figures arranged from very happy to very dissatisfied. Children are asked to indicate which face best describes their feelings at that moment. This scale is scored by giving the value of one to the most positive face and five to the most negative face. One interview will be done before the intervention and the other after the intervention. In the next step, in order to increase the confidence and also to reduce the percentage of errors in execution and the results of the study, the child's cortisol level (measured with a commercial kit), heart rate and blood pressure will be measured by the doctor before and after the intervention. Intervention 3: Control group: In relation to the control group in the study, in order to provide a basis for comparing the effect of aromatherapy on the intervention and control groups, this group is deprived of routine treatment, but in order to perform the study in equal conditions to assess anxiety, first interview with children. The face image scale (FIS) tool will be done. The FIS scale consists of a row of five figures arranged from very happy to very dissatisfied. Children are asked to indicate which face best describes their feelings at that moment. This scale is scored by giving the value of one to the most positive face and five to the most negative face. In the next step, in order to increase the confidence and also to reduce the percentage of errors in execution and the results of the study, the child's cortisol level (measured with a commercial kit), heart rate and blood pressure will be measured by the doctor before and after the intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Its release schedule is not yet known</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Mohamad Reza Tohidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah University of Medical Sciences, Shahid Beheshti Blvd</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714869914</zip>
        <telephone>+98 83 3835 8943</telephone>
        <email>tohidimohamadreza63@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Mohamad Reza Tohidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah University of Medical Sciences, Shahid Beheshti Blvd</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714869914</zip>
        <telephone>+98 83 3835 8943</telephone>
        <email>tohidimohamadreza63@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 6 to 12 years
Patient's consent to the use of clinical information in research purposes (in order to maintain the professional principles of research ethics)</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>A person has cognitive problems or anxiety disorders
Taking drugs that affect the central nervous system, with a sedative or anxiety relief effect</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other anxiety disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The substance used in this study in connection with intervention group 1 will contain jasmine essential oil. The electric fragrance diffuser will be used in the patients' presence space on the assigned days according to the sections mentioned). The device will start 30 minutes before the patient is present. Based on clinical experience and to receive essential oil with a constant medium concentration, 2 ml of essential oil will be used. The timer will be set to activate every 10 minutes for 2 minutes. To assess anxiety, children will first be interviewed using the face image scale (FIS) tool. The FIS scale consists of a row of five figures arranged from very happy to very dissatisfied. Children are asked to indicate which face best describes their feelings at that moment. This scale is scored by giving the value of one to the most positive face and five to the most negative face. One interview will be done before the intervention and the other after the intervention. In the next step, in order to increase the confidence and also to reduce the percentage of errors in execution and the results of the study, the child's cortisol level (measured with a commercial kit), heart rate and blood pressure will be measured by the doctor before and after the intervention.</i_keyword>
      <i_keyword>Intervention group 2: The substance used in this study in connection with intervention group 2 will include bitter orange essential oil. An electric fragrance diffuser will be used in the patient's presence space (on assigned days according to the sections mentioned). The device will start 30 minutes before the patient is present. Based on clinical experience and to receive essential oil with a constant medium concentration, 2 ml of essential oil will be used. The timer will be set to activate every 10 minutes for 2 minutes. To assess anxiety, children will first be interviewed using the face image scale (FIS) tool. The FIS scale consists of a row of five figures arranged from very happy to very dissatisfied. Children are asked to indicate which face best describes their feelings at that moment. This scale is scored by giving the value of one to the most positive face and five to the most negative face. One interview will be done before the intervention and the other after the intervention. In the next step, in order to increase the confidence and also to reduce the percentage of errors in execution and the results of the study, the child's cortisol level (measured with a commercial kit), heart rate and blood pressure will be measured by the doctor before and after the intervention.</i_keyword>
      <i_keyword>Control group: In relation to the control group in the study, in order to provide a basis for comparing the effect of aromatherapy on the intervention and control groups, this group is deprived of routine treatment, but in order to perform the study in equal conditions to assess anxiety, first interview with children. The face image scale (FIS) tool will be done. The FIS scale consists of a row of five figures arranged from very happy to very dissatisfied. Children are asked to indicate which face best describes their feelings at that moment. This scale is scored by giving the value of one to the most positive face and five to the most negative face. In the next step, in order to increase the confidence and also to reduce the percentage of errors in execution and the results of the study, the child's cortisol level (measured with a commercial kit), heart rate and blood pressure will be measured by the doctor before and after the intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety rate. Timepoint: 30 minutes after the start of the intervention. Method of measurement: using FIS scale, heart rate, pulse and blood pressure, cortisol ELISA diagnostic kit.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-02-08</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Ethics committee of Kermanshah University of Medical Sciences, Shahid Beheshti Blvd Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
